Resources
Download this reportCombating Aids
Inside this issue
• Scientists have announced the first partial success in the search for a vaccine, but there is still a long way to go
• A country that hoped to make prevention the cure
• Video: An assessment of the battle against the virus - -
Content
Funding fears overshadow progress
The rate of increase in HIV cases is slowing and drugs are improving – but access to them is patchy, writes Andrew Jack
Business: Corporate world lends big guns to battle the disease
Companies are benefiting from supplying skills, says Sarah Murray
Drugs: Cost is the highest barrier for treatments
Pharmaceutical companies are collaborating more and more, writes Andrew Jack
Vaccines: Hopes of prevention receive shot in the arm
Clive Cookson says the seemingly impossible has been achieved – now for the hard part
Preventing Aids
Editorial Comment: Politicians cannot turn their backs on Aids, which still kills 2m people a year, while 33.4m have HIV. But they must improve how they spend future funds
Focus is on cheaper and quicker tests
The need to increase HIV testing in developing countries brings with it a host of challenges, writes Alexandra Stevenson
South Africa: Dark days of denial firmly in the past
Richard Lapper studies the effects of a policy shift
Guest Column: Disparities around the world can and must end
No child should be born with HIV anywhere in the world, writes Carla Bruni-Sarkozy
Prevention: Simple solutions offer most promise
But better targeting of those easy answers is needed, says Andrew Jack
Over-50s cases raise concern
Reducing risky behaviours among older people also helps protect younger ones, writes Andrew Jack
